JADO Technologies GmbH
🇩🇪Germany
Efficacy and Safety of TF002 in Cutaneous Mastocytosis
Phase 2
Completed
- Conditions
- Cutaneous Mastocytosis
- First Posted Date
- 2007-04-06
- Last Posted Date
- 2007-11-12
- Lead Sponsor
- JADO Technologies GmbH
- Target Recruit Count
- 30
- Registration Number
- NCT00457288
- Locations
- 🇩🇪
Klinik und Poliklinik für Dermatologie und Venerologie der Universität, Köln, Germany
🇩🇪Klinik und Poliklinik für Dermatologie und Allergologie der LMU, München, Germany
🇩🇪Universitäts-Hautklinik, Mainz, Germany
© Copyright 2025. All Rights Reserved by MedPath